|

Carvedilol Clinical Trials

8 actively recruiting trials across 2 locations

Also known as: Coreg, carvid

Pipeline

Phase 3: 1Phase 4: 5Phase 2/3: 1

Top Sponsors

University of Rochester1
Taipei Veterans General Hospital, Taiwan1
Sherief Abd-Elsalam1
SWOG Cancer Research Network1
Post Graduate Institute of Medical Education and Research, Chandigarh1

Indications

Liver Disease5
Heart Disease3
Portal Hypertension2
Esophageal Varices2
Cancer2

Other6 trials

Acute Portal Pressure Reduction by Metformin and Carvedilol Compared to Carvedilol Alone in Cirrhosis.

N/A

Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of Oesophageal Varices Trial.

Phase 4

Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal Bleeding

Phase 2/3

DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis

Phase 4

Endoscopic Variceal Ligation vs Carvedilol for the Prevention of First Esophageal Variceal Bleeding in Patients With HCC

Phase 4

Non-selective Beta-blocker in Compensated Advanced Chronic Liver Disease

Phase 4

Anchorage, Alaska1 trial

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Anchorage Associates in Radiation Medicine

Phase 3

Scottsdale, Arizona1 trial

Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator

HonorHealth

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.